GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Leoclan Co Ltd (TSE:7681) » Definitions » Return-on-Tangible-Equity

Leoclan Co (TSE:7681) Return-on-Tangible-Equity : 0.00% (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Leoclan Co Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Leoclan Co's annualized net income for the quarter that ended in Mar. 2025 was 円0 Mil. Leoclan Co's average shareholder tangible equity for the quarter that ended in Mar. 2025 was 円5,620 Mil. Therefore, Leoclan Co's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2025 was 0.00%.

The historical rank and industry rank for Leoclan Co's Return-on-Tangible-Equity or its related term are showing as below:

TSE:7681' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 2.43   Med: 8.36   Max: 19.1
Current: 2.43

During the past 8 years, Leoclan Co's highest Return-on-Tangible-Equity was 19.10%. The lowest was 2.43%. And the median was 8.36%.

TSE:7681's Return-on-Tangible-Equity is ranked worse than
77.36% of 106 companies
in the Medical Distribution industry
Industry Median: 8.265 vs TSE:7681: 2.43

Leoclan Co Return-on-Tangible-Equity Historical Data

The historical data trend for Leoclan Co's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Leoclan Co Return-on-Tangible-Equity Chart

Leoclan Co Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Return-on-Tangible-Equity
Get a 7-Day Free Trial 2.75 8.18 8.53 5.03 2.48

Leoclan Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.87 10.09 -2.19 -3.91 -

Competitive Comparison of Leoclan Co's Return-on-Tangible-Equity

For the Medical Distribution subindustry, Leoclan Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Leoclan Co's Return-on-Tangible-Equity Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Leoclan Co's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Leoclan Co's Return-on-Tangible-Equity falls into.


;
;

Leoclan Co Return-on-Tangible-Equity Calculation

Leoclan Co's annualized Return-on-Tangible-Equity for the fiscal year that ended in Sep. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Sep. 2024 )  (A: Sep. 2023 )(A: Sep. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Sep. 2024 )  (A: Sep. 2023 )(A: Sep. 2024 )
=136.057/( (5483.954+5495.986 )/ 2 )
=136.057/5489.97
=2.48 %

Leoclan Co's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2025 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2025 )  (Q: Sep. 2024 )(Q: Mar. 2025 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2025 )  (Q: Sep. 2024 )(Q: Mar. 2025 )
=0/( (5495.986+5743.654)/ 2 )
=0/5619.82
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2025) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Leoclan Co  (TSE:7681) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Leoclan Co Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Leoclan Co's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Leoclan Co Business Description

Traded in Other Exchanges
N/A
Address
2-4-26 Senrioka, Settsu-shi, Osaka, JPN, 566-0001
Leoclan Co Ltd is a Japanese based medical equipment trading company that meets all medical, welfare and health needs.

Leoclan Co Headlines

No Headlines